Relationship between homocysteine and chronic total coronary occlusion: a cross-sectional study from southwest China

Kaiyong Xiao1, Zhe Xv2, Liang Liu3

  • 1Department of Cardiology, Guangyuan Central Hospital, Guangyuan, SC, China.

Cardiology in the Young
|October 9, 2023
PubMed

Insights

Elevated homocysteine levels are significantly linked to chronic total coronary occlusion, a complex heart condition. This association is particularly strong in older individuals and those with diabetes or hypertension.

Area of Science:

  • Cardiology
  • Biochemistry
  • Public Health

Background:

  • Chronic total coronary occlusion (CTO) represents a complex challenge in cardiovascular medicine.
  • Elevated homocysteine is a known risk factor for coronary artery diseases, but its specific role in CTO requires further investigation.

Purpose of the Study:

  • To investigate the association between homocysteine levels and the prevalence of chronic total coronary occlusion in a Chinese population.
  • To identify whether homocysteine is an independent risk factor for CTO.

Main Methods:

  • A study involving 1295 individuals from Southwest China.
  • Analysis of homocysteine levels divided into quartiles, with CTO defined as >3 months of complete coronary artery occlusion.
  • Statistical methods included logistic regression, ROC curves, and subgroup analyses.

Main Results:

  • Higher homocysteine quartiles correlated with increased rates of CTO (P < 0.001).
  • Elevated homocysteine (≥ 15.2 μmol/L) was an independent predictor of CTO (OR 1.53, P=0.0265).
  • The association was more pronounced in elderly individuals and those with hypertension and diabetes.

Conclusions:

  • Elevated homocysteine is significantly associated with chronic total coronary occlusion.
  • Homocysteine serves as an independent indicator for CTO, especially in vulnerable subgroups like the elderly and patients with comorbidities.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
19
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
13
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
101
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23